PROCTOZONE-P
Live / Applied — First extension granted (statement of use) (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 16 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98804929
- Mark type
- Word mark
- Filed
- 16 Oct 2024
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Nichole T. Hayden
Goods and services
- Class 005 — Pharmaceuticals: hemorrhoidal suppository; phenylephrine suppository for treating nasal congestion
Owner
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
Prior registrations
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 1 GRANTED
- 24 Feb 2026 — SOU EXTENSION 1 FILED
- 24 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Mar 2025 — NON-FINAL ACTION E-MAILED
- 08 Mar 2025 — NON-FINAL ACTION WRITTEN